Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack (Q24241777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

1 reference

title

Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Lorna M Gibson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ming Liu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

15 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

CD000248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19370555%20AND%20SRC:MED&resulttype=core&format=json

Trial of long-term anticoagulant therapy in the treatment of small stroke associated with a normal carotid arteriogram

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

A long-term study of cerebral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

A cooperative study of cerebrovascular disease; methodology and a preliminary report on the use of anticoagulants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Anticoagulant therapy in cerebral infarction. Report on cooperative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Anticoagulants for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Why is the outcome of transient ischaemic attacks different in different groups of patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Anticoagulant therapy in cerebrovascular disease: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Hypertension management and stroke recurrence in a community (Rochester, Minnesota, 1950-1979)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

SEPIVAC: a community-based study of stroke incidence in Umbria, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Survival and recurrence following stroke. The Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Trends in Five-Year Survival and Risk of Recurrent Stroke after First-Ever Stroke in the Perth Community Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248.PUB2

Questions and answers on prothrombin time standardisation in oral anticoagulant control.

21 January 2018

1 reference

12 December 2020

CEREBRAL APOPLEXY. A CLINICAL, RADIOLOGICAL, ELECTROENCEPHALOGRAPHIC AND PATHOLOGICAL STUDY WITH SPECIAL REFERENCE TO THE PROGNOSIS OF CEREBRAL INFARCTION AND THE RESULT OF LONG-TERM ANTICOAGULATION THERAPY

1 reference

12 December 2020

Long-term anticoagulant therapy in patients with cerebral infarction. A crontrolled clinical study

1 reference

12 December 2020

Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack

1 reference

12 December 2020

CEREBRAL VASCULAR DISEASE IN RELATION TO LONG-TERM ANTICOAGULANT THERAPY

1 reference

12 December 2020

Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack

1 reference

12 December 2020

Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project

1 reference

12 December 2020

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group

1 reference

12 December 2020

LONG-TERM ANTICOAGULANT THERAPY IN TRANSIENT CEREBRAL ISCHAEMIC ATTACKS

1 reference

12 December 2020

Survival following stroke

1 reference

12 December 2020

Risk of Myocardial Infarction or Vascular Death After First Ischemic Stroke

1 reference

12 December 2020

Stroke attack rates and case fatality in the Krakow Stroke Registry.

1 reference

12 December 2020

Analysis of 30-day stroke mortality in a community-based registry in Warsaw, Poland

1 reference

12 December 2020

A controlled clinical trial of long-term anticoagulant therapy in cerebrovascular disease

1 reference

12 December 2020

An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease. Report of the Veterans Administration Cooperative Study of Atherosclerosis, Neruology Section

1 reference

12 December 2020

Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks

1 reference

12 December 2020

Anticoagulant therapy in cerebral thrombosis and cerebral embolism. A national cooperative study, interim report

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks

1 reference

12 December 2020

Ambulatory treatment with anticoagulents in the prevention of cerebral ischemia

1 reference

12 December 2020

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

12 December 2020

Cerebrovascular disease: trial of long-term anticoagulant therapy.

1 reference

12 December 2020